Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease

참고문헌 (9)

1. Laura Rotundo, "The association of leptin with severity of non-alcoholic fatty liver disease: A population-based study", Clinical and Molecular Hepatology, 24(4), pp.392~401 (2018), 대한간학회
2. Targher G, "Non-alcoholic fatty liver disease and risk of incident cardiovascular disease : a meta-analysis", J Hepatol, 65, pp.589~600 (2016)
3. Motamed N, "Non-alcoholic fatty liver disease(NAFLD)and 10-year risk of cardiovascular diseases", Clin Res Hepatol Gastroenterol, 41, pp.31~38 (2017)
4. Yang H, "Leptin concentration and risk of coronary heart disease and stroke : a systematic review and meta-analysis", PLoS One, 12, pp.e0166360~ (2017)
5. Chai SB, "Leptin and coronary heart disease : a systematic review and meta-analysis", Atherosclerosis, 233, pp.3~10 (2014)
6. Martin SS, "Leptin and incident cardiovascular disease : the Multi-ethnic Study of Atherosclerosis(MESA)", Atherosclerosis, 239, pp.67~72 (2015)
7. Kim D, "Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States", Hepatology, 57, pp.1357~1365 (2013)
8. Baik M, "Liver fibrosis, not steatosis, associates with long-term outcomes in ischaemic stroke patients", Cerebrovasc Dis, 47, pp.32~39 (2019)
9. Younossi Z, "Global burden of NAFLD and NASH : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 15, pp.11~20 (2018)

관련 논문AI추천